0.195
price down icon12.08%   -0.0268
 
loading

Finanzdaten der Io Biotech Inc-Aktie (IOBT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
16.47%
19.36
23.17 22.58 26.94 26.50
Operating Income/Loss
16.47%
-19.36
-23.17 -22.58 -26.94 -26.50
Nonoperating Income/Loss
417.96%
9.313
-2.929 0.309 -3.945 2.698
Income/Loss From Continuing Operations Before Tax
61.52%
-10.04
-26.10 -22.27 -30.89 -23.81
Income Tax Expense/Benefit
1,510%
-1.664
0.118 0.146 0.445 0.209
Income/Loss From Continuing Operations After Tax
68.04%
-8.378
-26.22 -22.42 -31.33 -24.02
Net Income/Loss
68.04%
-8.378
-26.22 -22.42 -31.33 -24.02
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.61%
66.94
65.88 65.88 - 65.88
Diluted Average Shares
1.61%
66.94
65.88 65.88 - 65.88
Basic Earnings Per Share
67.50%
-0.13
-0.40 -0.34 -0.48 -0.36
Diluted Earnings Per Share
67.50%
-0.13
-0.40 -0.34 -0.48 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):